Legal Notice

 

The Pharmacy Show is sponsored by the pharmaceutical and med tech industries via Grants, Sponsorship, and Exhibition packages. Pharmaceutical companies have solely provided sponsorship through the purchase of exhibition space and/or sponsored speaker sessions with no further input into the arrangements or agenda of the meeting. Sessions delivered with input from our sponsors will always be marked on the programme. A full list of confirmed sponsors for PS24 is available here.

 

 

NEC BIRMINGHAM
12-13 OCTOBER 2025

23 Aug 2024

elénzia MEDICAL™ launches Imunoglukan® in the United Kingdom and Ireland: A Proven Paediatric Supplement to Boost Immune Health

Elenzia
elénzia MEDICAL™
elénzia MEDICAL™ launches Imunoglukan® in the United Kingdom and Ireland: A Proven Paediatric Supplement to Boost Immune Health
Imunoglukan® a paediatric supplement which main active ingredient is patented Pleuran, a highly purified beta-1,3/1,6-D-glucan derived from oyster mushrooms (Pleurotus ostreatus) that works synergistically with Vitamin C.
Redditch, August 2024– elénzia MEDICAL™, a leader in scientifically supported health and wellness products, is proud to announce that it is the sole distributor of Imunoglukan® in the UK and Ireland

Imunoglukan® is a paediatric supplement designed to contribute to the normal function of the immune system. This proven product features patented Pleuran as its main active ingredient. Pleuran, a highly purified beta-1,3/1,6-D-glucan derived from oyster mushrooms (Pleurotus ostreatus), works synergistically with Vitamin C. Together, these components offer a natural and effective way to support immune function in children aged 3 years and above.

Clinical Benefits:

  • Supports Immune Function and Reduces Fatigue: Imunoglukan® helps maintain a robust immune system while ensuring children stay active and healthy.
  • Protects Cells from Oxidative Stress: The supplement's antioxidant properties protect cells from oxidative damage, promoting overall well-being.

Potential Impact:

  • Reducing Paediatric Recurrent Respiratory Tract Infections (RRTIs): By strengthening the immune system, Imunoglukan® supports the decrease of frequency and severity of recurrent respiratory tract infections in children.
  • Addressing Antimicrobial Resistance (AMR): Enhanced immune support could reduce the reliance on antibiotics, contributing to the fight against antimicrobial resistance.

As the exclusive UK and Ireland distributor of Imunoglukan®, elénzia MEDICAL™ is committed to providing paediatric healthcare professionals and pharmacists with access to this proven, ground-breaking supplement. Dedicated to science, efficacy, and wellness, drives elénzia MEDICAL™ to offer products that make a difference in people's lives.

 

About elénzia MEDICAL™: elénzia MEDICAL™ thrives on improving the lifestyle of its community and their loved ones. Their mission is to deliver proven products backed by the latest scientific research, clinical trials, and healthcare trends. Aiming to provide tangible benefits that enhance overall wellness, ensuring that the products they offer are scientifically supported and carefully formulated for incredible results.

For more information, please contact: emily@elenzia.com

View all Exhibitor News
Loading

2024 PARTNERS AND SPONSORS

Supported By

Sponsored By

Platinum App Sponsor

Gold App Sponsor

Education Partners

Official Media Partner

Official Digital Partner

Official Publications

Media Partners

Digital Partner

Charity Partners

Official Covid & Flu Jab Training

Career Partner